摘要
目的评价中医药治疗急性心肌梗死的有效性和安全性。方法设计随机临床试验的系统评价。检索中医药治疗急性心肌梗死的随机临床试验。无论使用盲法与否或以何种语言发表均无限制。结果 56篇文章符合纳入标准,对其中17篇Jadad评分质量相对较高的文章进行系统评价,结果显示中医药可以减少急性心肌梗死患者溶栓并发症,降低患者死亡率,提高患者临床总体疗效。结论根据本系统评价,中医药治疗急性心肌梗死安全有效,不良反应轻微。
Objective To assess the therapeutic effect and safety of Chinese medicine in treating acute myocardial infarction（AMI）.Design：Systematic review of randomized clinical trials（RCT）.Methods The systematic review of randomized clinical trials（RCT） was disigned.Literatures regarding randomized clinical trials of Chinese medicine in treating AMI,whether using blind methods or not and without any language limitation.Results Fifty-six randomized trials met the inclusion criteria and the systematic review was applied for 17 literatures which Jadad scores were relatively high.And the results showed that Chinese medicine could reduce thrombolysis complications and mortality,improve clinical curative effect,and side effects were rare.Conclusion Based on the systematic review,Chinese medicine showed therapeutic effects in treating AMI.
出处
《中西医结合心脑血管病杂志》
2011年第5期513-515,共3页
Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
基金
国家中医药管理局公益性行业科研专项基金--基于糖尿病周围神经病变等7个单病种中医最佳诊疗方案的临床路径共性技术研究(No.200707004)
关键词
中医药
急性心肌梗死
系统评价
Chinese medicine
acute myocardial infarction
systematic review
